Browse by:
Launch and learn

Launch and learn

First-time biotech launches are on the rise, find partners Pablo Salazar and Peter Wright and coauthors.

A boon for biotech

A boon for biotech

Biotech start-ups with next-generation platform technologies—such as new therapeutic delivery methods and machine-learning-enabled drug discovery—have captured the lion’s share of recent venture-capital (VC) investment in the industry.

Subscribe to The Week in Charts

Our best data-driven visuals, delivered to your inbox each Saturday
Patently inferior?

Patently inferior?

The United Kingdom has always had a reputation for scientific excellence, with world-class universities and Nobel laureates by the dozen.

Biotech booms

Biotech booms

Biotech companies continue to grow and attract major funding from both public and private sources.

Premiums for proteins

Premiums for proteins

It won’t be easy or quick to cut production costs for cultivated meat.

Cheap eats

Cheap eats

In less than a decade, companies have been able to reduce the production costs of cultivated meat by 99 percent.

The real thing

The real thing

Today, the world primarily eats the meat of animals that are the easiest to farm industrially.

Viruses as a force for good

Viruses as a force for good

Excitement about viral-vector gene therapies is growing.